ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,352Hybrid

Nanotoxicology

Acronym:tnan
•
Abbreviation (ISO):NANOTOXICOLOGY
•
Identifier (ISSN):1743-5390(Print)/1743-5404(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
3.6↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Nanotoxicology

WoS Q3
24685.8120185.9620194.9220205.9120215.882022520233.620243.420253.62026
Annual Impact Factor Metric
Current (2026):3.6
Scopus SJR & RankScopus Q2
0.693
#8,352

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
116

116 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate2.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
48articles/year
17.54% Gold OA•90.91% Original Research

Aims & Scope

Nanotoxicology invites contributions addressing research relating to the potential for human and environmental exposure, hazard and risk associated with the use and development of nano-structured materials. In this context, the term nano-structured materials has a broad definition, including ‘materials with at least one dimension in the nanometer size range’. These nanomaterials range from nanoparticles and nanomedicines, to nano-surfaces of larger materials and composite materials. The range of nanomaterials in use and under development is extremely diverse, so this journal includes a range of materials generated for purposeful delivery into the body (food, medicines, diagnostics and prosthetics), to consumer products (e.g. paints, cosmetics, electronics and clothing), and particles designed for environmental applications (e.g. remediation). It is the nano-size range if these materials which unifies them and defines the scope of Nanotoxicology . While the term ‘toxicology’ indicates risk, the journal Nanotoxicology also aims to encompass studies that enhance safety during the production, use and disposal of nanomaterials. Well-controlled studies demonstrating a lack of exposure, hazard or risk associated with nanomaterials, or studies aiming to improve biocompatibility are welcomed and encouraged, as such studies will lead to an advancement of nanotechnology. Furthermore, many nanoparticles are developed with the intention to improve human health (e.g. antimicrobial agents), and again, such articles are encouraged. In order to promote quality, Nanotoxicology will prioritise publications that have demonstrated characterisation of the nanomaterials investigated.

Topics Covered (Recognized by AI)
Chemistry91.2%Biology91.2%Medicine83.6%Materials science79.8%Organic chemistry73.5%Internal medicine72.9%Biochemistry71.6%Genetics68.5%Engineering68.3%Physics67.8%Nanotechnology66.9%Chemical engineering64.9%Quantum mechanics57.2%Nanoparticle49.7%Toxicity48.6%Biophysics33.1%Cell biology31.1%In vitro31.1%Endocrinology27.1%Gene24%Immunology23.5%Nanotoxicology23.5%Composite material22%Metallurgy21.3%Geology20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Q3
Rank87/148
IndexSCIE
JCRSCIE2026

TOXICOLOGY

Q2
Rank35/106
IndexSCIE
JCISCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Q2
Rank74/148
IndexSCIE
JCISCIE2026

TOXICOLOGY

Q3
Rank73/106
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.6
Articles / Year21
Total Citations10
2025
IF3.4
Articles / Year34
Total Citations142
2024
IF3.6
Articles / Year41
Total Citations351
2023
IF5
Articles / Year40
Total Citations350
2022
IF5.881
Articles / Year55
Total Citations634

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,352Scopus Q2SCImago Profile
Scopus Coverage:2007-2026
Scopus Broad Areas:EngineeringMaterials SciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.693

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.99

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,208 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations475
3-Year Documents127
Citable Documents126

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate52.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biomedical EngineeringQ2
Nanoscience and NanotechnologyQ2
ToxicologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区NANOSCIENCE & NANOTECHNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Nanotoxicology (acronym: tnan, abbr: NANOTOXICOLOGY, ISSN: 1743-5390) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in England since 2007. The periodical holds a Journal Impact Factor (JIF) of 3.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.693 (Q2), an H-index of 116.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 48 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,208 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Quarterly
Founding Year
2007
Indexing & Databases
SCIEScopusPubMed
Editorial Address
INFORMA HEALTHCARE, 52 VANDERBILT AVE, NEW YORK, USA, NY, 10017

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 97a5bd8d-35aa-4a8c-804c-38bcc109c78e
Database Updated: 2026-10-01